Go Pro

Ligand Pharmaceuticals (LGND) Stock Chart & Stock Price History

Ligand Pharmaceuticals logo
$291.77 -2.83 (-0.96%)
Closing price 08/17/2026 04:00 PM Eastern
Extended Trading
$291.83 +0.06 (+0.02%)
As of 04:56 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ligand Pharmaceuticals Stock Price Performance

The Ligand Pharmaceuticals (LGND) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 90.38%, with a year-to-date return of 54.32%. In the past month, the stock has decreased 3.83%, reflecting recent market activity.

As of the latest close, Ligand Pharmaceuticals traded at $291.77 with a market cap of $5.82 billion and volume of 145,586 shares. Five years ago, the stock traded at $105.30, representing a 177.08% increase over that period. At the time, it had a market cap of $1.76 billion and a volume of 138,019 shares.

Receive LGND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ligand Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+1.02%
1 Month
Performance
-3.83%
3 Month
Performance
+40.35%
Year-To-Date
Performance
+54.32%
1 Year
Performance
+90.38%
5 Year
Performance
+177.08%

LGND Stock Chart for Tuesday, August, 18, 2026

Ligand Pharmaceuticals Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
08/17/2026$294.60$291.77
-0.96%
$298.29$291.73145,586 shs$5.82 billion
08/14/2026$288.82$294.60
+2.00%
$295.19$287.20197,208 shs$5.87 billion
08/13/2026$293.27$288.82
-1.52%
$294.99$285.24255,435 shs$5.76 billion
08/12/2026$288.75$293.27
+1.57%
$294.75$287.81372,332 shs$5.85 billion
08/11/2026$295.70$288.75
-2.35%
$299.34$288.60368,549 shs$5.79 billion
08/10/2026$293.15$295.70
+0.87%
$299.39$288.46192,187 shs$5.93 billion
08/07/2026$300.14$293.15
-2.33%
$304.60$286.65313,611 shs$5.88 billion
08/06/2026$302.57$300.14
-0.80%
$317.49$297.31391,885 shs$6.01 billion
08/05/2026$300.79$302.57
+0.59%
$308.56$300.07197,093 shs$6.06 billion
08/04/2026$292.04$300.79
+3.00%
$301.67$293.76329,155 shs$6.03 billion
08/03/2026$287.54$292.04
+1.56%
$293.23$283.77191,741 shs$5.85 billion
07/31/2026$296.29$287.54
-2.95%
$301.92$286.22259,862 shs$5.76 billion
07/30/2026$288.01$296.29
+2.87%
$303.00$286.45270,980 shs$5.94 billion
07/29/2026$296.28$288.01
-2.79%
$298.29$287.19356,724 shs$5.77 billion
07/28/2026$297.50$296.28
-0.41%
$301.29$293.53353,452 shs$5.94 billion
07/27/2026$300.53$297.50
-1.01%
$304.97$293.02378,442 shs$5.96 billion
07/24/2026$302.15$300.53
-0.54%
$307.81$297.17264,707 shs$6.02 billion
07/23/2026$304.26$302.15
-0.69%
$307.48$300.00355,486 shs$6.06 billion
07/22/2026$305.47$304.26
-0.40%
$308.56$302.20205,458 shs$6.10 billion
07/21/2026$293.99$305.47
+3.90%
$305.47$295.35162,765 shs$6.12 billion
07/20/2026$303.39$293.99
-3.10%
$308.56$293.69395,572 shs$5.89 billion
07/17/2026$296.45$303.39
+2.34%
$305.60$290.20278,328 shs$6.08 billion

This page (NASDAQ:LGND) was last updated on 8/17/2026 by MarketBeat.com Staff.
From Our Partners